343. The longevity factor: how aging is transforming financial planning

As our expected lifespans increase, so does the complexity of long-term financial planning. In this episode, we explore how societal shifts, like extended careers and aging demographics, influence our financial goals. Carl Stick, co-manager of the Rathbone Income fund, gives his insights into the vital role of dividends, the importance of compounding, and how companies are embracing older workers. Carl and Darius also discuss the evolving opportunities in sectors like healthcare and pharmaceuticals, where innovation meets the challenges of longevity. Whether you're planning for retirement or considering the future impact of aging populations, this episode offers a timely perspective to help you navigate your financial planning.

What’s covered in this episode: 

• The impact of increasing longevity on investing goals
• How aging workforces affect global economies, pension schemes, and healthcare systems
• Companies actively recruiting older workers
• Companies offering apprenticeships for those over 50
• The importance of finding purpose in later-life work
• The role of dividends in long-term investment growth and income flexibility
• Why it’s never too late to start investing
• The influence of demographic shifts in Japan and China on workforce dynamics
• A focus on industries like pharmaceuticals and healthcare
• Key investment themes linked to longevity

More about the fund: The Rathbone Income fund gives investors exposure to a concentrated portfolio of companies with high quality and visible earnings. The managers are unconstrained in terms of sector weightings and are able to fully express their market views with the portfolio positioning. The fund usually consists of between 30 and 50 holdings. It invests predominantly in UK equities (80% or more), while up to 20% of the total may be held in cash and overseas equities.

Learn more on fundcalibre.com

Please remember, we’ve been discussing individual companies to bring investing to life for you. It’s not a recommendation to buy or sell. The fund may or may not still hold these companies at the time of listening. Elite Ratings are based on FundCalibre’s research methodology and are the opinion of FundCalibre’s research team only.